Search Result "AP23573"
Mammalian Target of Rapamycin as a Therapeutic Target in Leukemia
Journal: Current Molecular Medicine
Volume: 5 Issue: 7 Year: 2005 Page: 653-661
Author(s): Francis J. Giles, Maher Albitar
Clinical Development of mTOR Inhibitors: A Focus on Lymphoma
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 2 Year: 2007 Page: 103-110
Author(s): Sonali M. Smith
The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors
Journal: Current Cancer Therapy Reviews
Volume: 4 Issue: 3 Year: 2008 Page: 227-234
Author(s): Arun Rajan, Ajeet Gajra
The Applicability of mTOR Inhibition in Solid Tumors
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 3 Year: 2009 Page: 439-450
Author(s): I.R. H.M. Konings, J. Verweij, E. A.C. Wiemer, S. Sleijfer
Promising Activity of Mammalian Target of Rapamycin Inhibitors in Hematologic Malignancies Therapy
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 44-54
Author(s): Ota Fuchs
mTOR Inhibition in Lymphoma: A Rational and Promising Strategy
Journal: Letters in Drug Design & Discovery
Volume: 4 Issue: 3 Year: 2007 Page: 224-231
Author(s): Sonali M. Smith, Koen van Besien
Advances in mTOR inhibitors
Ebook: Advances in Anticancer Agents in Medicinal Chemistry
Volume: 1 Year: 2013
Author(s): Hongyu Zhou,Shile Huang
Doi: 10.2174/9781608054930113010006
Novel Therapeutic Approaches in Pancreatic Cancer Based on Genomic Alterations
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 17 Year: 2012 Page: 2452-2463
Author(s): Shinichi Yachida
Discovery and Development of ATP-Competitive mTOR Inhibitors Using Computational Approaches
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 29 Year: 2017 Page: 4321-4331
Author(s): Yao Luo,Ling Wang
Personalized Medicine for Pediatric AML: New Targeted Strategies
Ebook: Topics in Anti-Cancer Research
Volume: 1 Year: 2012
Author(s): Riccardo Masetti,Katharina Kleinschmidt,Carlotta Biagi,Andrea Pession
Doi: 10.2174/9781608054787112010012